Literature DB >> 33747742

Hairpin-Spacer crRNA-Enhanced CRISPR/Cas13a System Promotes the Specificity of Single Nucleotide Polymorphism (SNP) Identification.

Yuqing Ke1, Shiyi Huang1, Behafarid Ghalandari1, Sijie Li1, Antony R Warden1, Jingqi Dang1, Lin Kang2, Yu Zhang1, Yunqing Wang1, Yiqing Sun1, Jinglin Wang1, Daxiang Cui3, Xiao Zhi1, Xianting Ding1.   

Abstract

The Cas13a system has great potential in RNA interference and molecular diagnostic fields. However, lacking guidelines for crRNA design hinders practical applications of the Cas13a system in RNA editing and single nucleotide polymorphism identification. This study posits that crRNAs with hairpin spacers improve the specificity of CRISPR/Cas13a system (termed hs-CRISPR). Gibbs free energy analysis suggests that the hairpin-spacer crRNAs (hs-crRNAs) suppress Cas13a's affinity to off-target RNA. A hepatitis B virus DNA genotyping platform is established to further validate the high-specificity of hs-CRISPR/Cas13a system. Compared to ordinary crRNA, hs-crRNAs increase the specificity by threefold without sacrificing the sensitivity of the CRISPR/Cas13a system. Furthermore, the mechanism of the Cas13a/hs-crRNA/target RNA composition is elucidated with theoretical simulations. This work builds on the fundamental understanding of Cas13a activation and offers significant improvements for the rational design of crRNA for the CRISPR/Cas13a system.
© 2021 The Authors. Published by Wiley‐VCH GmbH.

Entities:  

Keywords:  CRISPR/Cas13a system; Gibbs free energy; crRNA design; hairpin structures; single nucleotide polymorphisms

Year:  2021        PMID: 33747742      PMCID: PMC7967054          DOI: 10.1002/advs.202003611

Source DB:  PubMed          Journal:  Adv Sci (Weinh)        ISSN: 2198-3844            Impact factor:   16.806


  7 in total

1.  A Highly Sensitive and Specific Detection Method for Mycobacterium tuberculosis Fluoroquinolone Resistance Mutations Utilizing the CRISPR-Cas13a System.

Authors:  Xiaopeng Bai; Panqi Gao; Keli Qian; Jiandong Yang; Haijun Deng; Tiwei Fu; Yuan Hu; Miaomiao Han; Huizhi Zheng; Xiaoxia Cao; Yuliang Liu; Yaoqin Lu; Ailong Huang; Quanxin Long
Journal:  Front Microbiol       Date:  2022-05-13       Impact factor: 6.064

2.  Recognition of DNA Target Formulations by CRISPR-Cas12a Using a dsDNA Reporter.

Authors:  Christopher W Smith; Mahera J Kachwala; Nidhi Nandu; Mehmet V Yigit
Journal:  ACS Synth Biol       Date:  2021-06-18       Impact factor: 5.249

3.  2'-O-Methyl modified guide RNA promotes the single nucleotide polymorphism (SNP) discrimination ability of CRISPR-Cas12a systems.

Authors:  Yuqing Ke; Behafarid Ghalandari; Shiyi Huang; Sijie Li; Chengjie Huang; Xiao Zhi; Daxiang Cui; Xianting Ding
Journal:  Chem Sci       Date:  2022-02-01       Impact factor: 9.825

4.  CRISPR-Cas13a cascade-based viral RNA assay for detecting SARS-CoV-2 and its mutations in clinical samples.

Authors:  Yuxi Wang; Ting Xue; Minjin Wang; Rodrigo Ledesma-Amaro; Ying Lu; Xinyue Hu; Ting Zhang; Ming Yang; Yalun Li; Jin Xiang; Ruijie Deng; Binwu Ying; Weimin Li
Journal:  Sens Actuators B Chem       Date:  2022-03-27       Impact factor: 9.221

5.  Injectable light-assisted thermo-responsive methylcellulose-sodium humate hydrogel proposed for photothermal ablation and localized delivery of cisplatin.

Authors:  Farnaz Ghorbani; Behafarid Ghalandari; Zichen Liu; Dejian Li; Baoqing Yu
Journal:  Front Bioeng Biotechnol       Date:  2022-08-08

6.  One-Pot Visual Detection of African Swine Fever Virus Using CRISPR-Cas12a.

Authors:  Chao Qin; Jiajia Liu; Wenqi Zhu; Muchu Zeng; Ke Xu; Jinmei Ding; Hao Zhou; Jianshen Zhu; Yuqing Ke; Lai Yan Li; Gaoyuan Sheng; Zhuoru Li; Huaixi Luo; Shengyao Jiang; Kangchun Chen; Xianting Ding; He Meng
Journal:  Front Vet Sci       Date:  2022-07-18

7.  Poly (N-vinylpyrrolidone) modification mitigates plasma protein corona formation on phosphomolybdate-based nanoparticles.

Authors:  Youyi Yu; Behafarid Ghalandari; Guangxia Shen; Liping Wang; Xiao Liu; Aiting Wang; Sijie Li; Haiyang Xie; Xianting Ding
Journal:  J Nanobiotechnology       Date:  2021-12-23       Impact factor: 10.435

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.